Call for Action2018

"Global Health & Antimicrobial Resistance: A Global Challenge"

World Federation of Public Health Associations: Improving Health Globally

WFPHA calls for integrated action on AMR – Join our call Now!

Call for ActionPress release

Call for Action - Spanish Version


Antimicrobial Resistance Workshop - Outcomes

The International Global Health & Antimicrobial Resistance Workshop hosted on May 23rd was a huge success with lively discussions between the audience of health professionals and our 26 high-level speakers from various health sectors. This interaction offered an interdisciplinary insight into the challenges and potential solutions of antimicrobial resistance (AMR).
The workshop was organized in a series of panels and discussions moderated by Bettina Borisch, Michael Moore, Laetitia Rispel and Marta Lomazzi. Speakers included high-level representatives like the Minister of Health of Ghana Honourable Kwaku Agyemang-Manu, Mark Sprenger, April Johnson, Manica Balasegaram, Viviana Munoz and the WFPHA immediate past president Michael Moore, just to cite a few...

World Health Organization (WHO), World Organization of Family Doctors (WONCA), International Pharmaceutical Federation (FIP), International Council of Nurses (ICN), Pfizer, Global Antibiotic Research & Development Partnership (GARDP), South Centre, Becton Dickinson (BD), React Europe, Food and Agricolture Organization (FAO), World Medical Association (WMA), TB Global Fund, European Public Health Alliance (EPHA), SustainAbility, Public Health Agency of Sweden, United Nations Conference on Trade and Development (UNCTAD), London School of Hygiene and Tropical Medicine (LSHTM UK), University of Antwerp, University of Manchester.
These organizations have played a key role in integrating conversations from different sectors to create effective partnership and cultivate an interdisciplinary knowledge that is accessible to all health professionals in the fight against antimicrobial resistance.

182315da 3c2e 4382 adcf d6ad1a3b77da182315da 3c2e 4382 adcf d6ad1a3b77da 

Over 250 delegates attended the workshop and special thanks to everyone for actively contributing to the discussions.
The WFPHA is grateful for all the support and the incredible response from all the attendees.

Highlights from the event

Marc Sprenger, Director of Antimicrobial Resistance Secretariat at the WHO, opened the workshop emphasizing the importance of education, action, behavioral change and political commitment in combating AMR from a global perspective.

Hon. Kwaku Agyemang-Manu, Minister of Health of Ghana, highlighted the significant achievements of the Republic of Ghana on AMR, announcing the implementation of an Antimicrobial Resistance policy with full government support.


Hon. Kaku Agyeman-Manu, Minister of Health Ghana (left) and Michael Moore, immediate past WFPHA president (right).

Some quotes


"We need mapping of production and supply - we need TRANSPARENCY" - Thomas Tängdén, ReAct Europe

"We have a business model that failed to produce antibiotics and failed to have equal distribution... We shouldn't just ask for a fair price, but ensure the continuity of production and stock management." - Thomas Tängdén, ReAct Europe


"The demand for animal production is always increasing. If we're not going to have healthy animals, we're not going to have healthy foods. 40% of countries are still using antimicrobials for growth production." - April Johnson, FAO

"There is an estimate of 390,000 deaths/year by 2050, but considering the stats from the past, this number is probably outdated. We need regulation, monitoring and surveillance obligations to know what we are dealing with." - Nina Renshaw, EPHA


"Pharmacists are essential players to the fight against AMR. They are not only accessible, but readily available when other health providers are not." - Philip Howard, FIP

"Fear is a driver of change, but there is not enough of it in AMR awareness. It is not the best emotion to promote, but we must get these patients' stories out to the public." - Gary Cohen, BD

"The value of losing antibiotics is critical as it is a global public good that we need to conserve for everyone. Many countries need to focus on prevention, but there are also others that must mitigate misuse." - Viviana Munoz, South Center

"Youth and young professionals can start talking about politics, discuss how we can get the money, keep the conversation going." - Nina Henshaw, EPHA


Small group sessions facilitated by Denise Denelay, Sonja Löfmark, Anette Hulth, Christoph Spennemann, Renuka Gadde, Rosanna Peeling, Roger Harrison, Herman Goossens, Thomas Tängdén, April Johnson, and Bettina Borisch have been run during the workshop to facilitate exchanges and to mentor young professionals.


Herman Goossens from the University of Antwerp closed the workshop by speaking on the need to establish antibiotic efficacy as a global public good.

WFPHA calls for integrated action on AMR

WFPHA has released a call to action at the end of the workshop for an integrated action on AMR. This call has been signed by over 60 health organizations worldwide.

The World Federation of Public Health Associations (WFPHA) has called on all governments, industry, NGOs, health professionals, public and private research organizations to ensure that public health remains at the centre of all policy and scientific endeavours to tackle the threat of antimicrobial resistance (AMR). The Federation proposes the establishment of antibiotic efficacy as a global public good.

AMR is one of the World Health Organization's (WHO) top priorities. Antimicrobial drugs have played a key role in both prevention and curing infections. However, overuse and misuse of antimicrobials in humans, animals, and agriculture; gaps in infection prevention and control; lack of quality medicines; and inadequate investments in new drug development may be placing the breakthroughs in treatment of infectious diseases over the past 50 years in peril.

During this year's World Health Assembly, WFPHA's call for action aims to direct all actors to use an upstream approach as outlined in the Global Charter for the Public's Health. Effective health services are essential to facilitate ongoing prevention, protection, and health promotion strategies to mitigate the adverse effects of AMR. Essential enablers for resilient and secure health systems include the maintenance of good governance, accurate information, capacity building, and effective advocacy.

"The last thing we need is to go backwards in terms of protecting the world from infection. AMR is one of our greatest challenges in protecting our people worldwide. Integrating all stakeholders to strengthen institutional strategies is essential to face antimicrobial resistance and develop sustainable health practices." said Michael Moore, the immediate past president of the WFPHA.

Dr Manica Balasegaram, Director of the Global Antibiotic Research and Development Partnership (GARDP), one of the workshops' keynote speakers said, "Developing new treatments to tackle AMR in isolation jeopardizes the public health return on investment of developing accessible treatments. It's important to move away from working in silos and find ways of bringing together science, policy and public health if we are to successfully address the challenges of AMR."

The Call for Action aims to direct all actors to appropriately apply the values and strategies outlined in the Global Charter for the Public's Health. This can be done through best practice that improves existing health services and enablers for a resilient health system. If your organization is interested in signing, please contact .

The Call to Action is supported by more than 50 organizations

New Diplomats of the Global Charter


During the workshop the Hon. Kwaku Agyeman-Manu has been awarded as Diplomat of the Global Charter for the Public's Health to recognize his efforts to spearhead improvements for public health in his country with a special focus on AMR. The minister dedicated this award to the president of Ghana, Hon. Nana Akufo-Addo, for his commitment and continuous support to promote public health in the country.


During the event, Antoine Flahault, Director of the Institute of Global Health (University of Geneva), has received the same recognition.

Four other senior public health leaders have been awarded in the same week as Diplomats of the Global Charter. These new Diplomats have joined other 24 committed public health leaders in implementing the Global Charter for the Public Health.

leftleft rightright

Left picture from left to right: Georges Benjamin (APHA), Raman Bedi (GCDF) Walter Ricciardi (SITI)
Right picture (center): Shih-Chung Chen

The WFPHA calls upon health organization to continue join the development of the Global Charter of Public Health to fully embrace and promote its services of protection, prevention and health promotion as well as its four enabler functions of good governance, accurate information, effective advocacy and capacity building. Utilization of these services and functions will serve as a pathway to resilient health systems globally.

BECOME A DIPLOMAT OF THE GLOBAL CHARTER NOW and sustain this global public health revolution!" For more info, connect here:

Sponsor and Supporters

This workshop was made possible by the generous support of our sponsors and supporters.

We thank our sponsors:

Screen Shot 2018 10 12 at 12.37.58Screen Shot 2018 10 12 at 12.37.58Screen Shot 2018 10 12 at 12.37.51Screen Shot 2018 10 12 at 12.37.51Screen Shot 2018 10 12 at 12.51.51Screen Shot 2018 10 12 at 12.51.51

We also would like to express our gratitude to our exhibitors: American Public Health Association (APHA), Global Antibiotic Research & Development Partnership (GARDP), Public Health Association of Australia (PHAA), and Public Library of Science (PLOS).
Stay tuned for next year's workshop on vaccination!

Confirmed speakers

amr child image with titleamr child image with title

  • Michael Moore, President, World Federation of Public Health Associations
  • Hon. Kwaku Agyemang-Manu, Minister of Health, Ghana
  • Marc Sprenger, Director, Antimicrobial Resistance Secretariat, WHO
  • Manica Balasegaram, Director, GARDP
  • April Johnson, Animal Health Officer, FAO
  • Herman Goossens, Professor of Microbiology, University Hospital, Antwerp
  • Peter Beyer, Senior Advisor, Dept of Essential Medicines & Health Products, WHO
  • Denise Delaney, Director, SustainAbility
  • Gary M. Cohen, President, Becton Dickinson and Co. Foundation
  • Renuka Gadde, Vice President, Global Health Becton Dickinson and Co.
  • Mohammed Yassin, Senior TB Advisor, Global Fund
  • Thomas Tangden, Medical Director, ReAct Europe
  • Caline Mattar, Instructor in Medicine, World Medical Association
  • Nina Renshaw, Secretary-General, EPHA
  • Howard Catton, Director, Nursing and Health Policy,  International Council of Nurses
  • Philip Howard, Consultant Pharmacist in AMR, International Pharmaceutical Federation
  • Stefano Aliberti, Head of the Respiratory Infections Assembly, European Respiratory Society
  • Anette Hulth, International Coordinator, Antibiotic and Infection Control, PH Agency of Sweden
  • Sonja Löfmark, Analyst for Antibiotic and Infection Control, PH Agency Sweden
  • Christoph Spennemann, Legal Officer, UNCTAD
  • Catharina Boehme, Chief Executive Officer, FIND
  • Viviana Munoz, Development, Innovation and Intellectual Property Programme, South Center
  • Nicholas Kitchin, Senior Director of Vaccine Clinical Research, Pfizer
  • Roger Harrison, Senior Lecturer in Public Health, University of Manchester
  • Amanda Howe, President, WONCA
  • Rosanna Peeling, Chair of Diagnostics Research, London School of Hygiene and Tropical Medicine
  • Bettina Borisch, Executive Director, WFPHA


To download the workshop booklet containing all important inforamtion please click here.


 Final Sponsors Logos v2Final Sponsors Logos v2



Campus Biotech

9 Chemin des Mines

1202 Geneva


Key contacts

  • Marta Lomazzi, PhD
    Executive Manager
    World Federation of Public Health Associations
    Tel: +41 22 3790455

  • Eleonora De Cata, PhD
    Office Manager
    World Federation of Public Health Associations
    Tel: +41 22 3790484


International Global Health & Antimicrobial Resistance

Establishing antibiotic efficacy as a global public good

Campus Biotech - Geneva, Switzerland – May 23rd

Time Session
8:30am– 8.45am Welcome and overview of the day
Address by Bettina Borisch
WFPHA Executive Director & Workshop Co-Chair
8:45am – 9:00am Keynote “Setting the scene: challenges in AMR from the Global Health perspective” 
Invited Speaker: Marc Sprenger, Director, Antimicrobial Resistance Secretariat, WHO
9:00am – 9:15am Keynote “Combating Antimicrobial Resistance in Ghana”
Invited Speaker: Hon. Kwaku Agyemang-Manu MP, Minister of Health, Ghana 
9.15am – 10.00am

Panel I

  • Amanda Howe – World Organization of Family Doctors (WONCA)
  • Stefano Aliberti – European Respiratory Society (ERS)
  • Philip Howard – International Pharmaceutical Federation (FIP)
  • Howard Catton – International Council of Nurses (ICN)
  • Nicholas Kitchin – Pfizer

Chair: Bettina Borisch

10.00am – 10.15am

Keynote “Public-health driven, non-profit drug development: The Global Antibiotic Research and Development Partnership”

Invited Speaker: Manica Balasegaram, GARDP Director

10.15am –


Panel II

  • Peter Beyer – World Health Organization (WHO)
  • Viviana Muñoz – South Centre 
  • Gary Cohen – BD Foundation
  • Catharina Boehme – FIND
  • Manica Balasegaram – GARDP

Chair: Michael Moore

11.00am – 11.15am

Keynote “Unavailability of old antibiotics – consequences and way forward”

Invited Speaker: Thomas Tängdén, React Europe

11.15 am – 11.45am Morning Tea and networking
11.45am – 12.00pm Keynote “Antimicrobial use and resistance in the food and agriculture sectors”
Invited Speaker: April Johnson, Animal Health Officer, FAO
12.00pm – 12.45pm

Panel III

  • April Johnson – Food and Agriculture Organization of the United Nations (FAO)
  • Caline Mattar – World Medical Association (WMA)
  • Mohammed Yassin – Senior Disease Advisor, TB Global Fund
  • Nina Renshaw – European Public Health Alliance (EPHA)
  • Michael Moore – World Federation of Public Health Association (WFPHA)

Chair: Laetitia Rispel

12:45pm – 1.45pm Lunch and networking
1:45pm – 2:00pm Award ceremony – Diplomat of the Global Charter conferred to A. Flahault
Delivered by Laetitia Rispel
WFPHA President 
2:00pm – 3:00pm

Facilitated group work (parallel sessions)

  • Private sector contributions to fight AMR 
    Denise Denelay – SustainAbility 
  • Global surveillance of AMR for national good 
    Sonja Löfmark & Anette Hulth – Public Health Agency of Sweden
  • How do we provide better investment incentives to address AMR? 
    Christoph Spennemann – UNCTAD
  • Role of Diagnostics in AMR (MOOC) 
    Renuka Gadde – BD Foundation & Rosanna Peeling – LSHTM UK
  • Public engagement – Action on Antibiotic Drug Resistance 'One studentone campusone world'
    Roger Harrison – University of Manchester UK
  • Do we need to establish antibiotic efficacy as a global public good? 
    Herman Goossens – University of Antwerp
  • What are the requirements for community-based point prevalence studies and surveillance mapping of resistance rates? 
    Thomas Tängdén – REACT EUROPE
  • How can we reduce and optimize the use of antimicrobials in animal production while maintaining animal welfare and food security? 
    April Johnson – FAO
  • Can the Global Charter for the Public’s Health be used in the implementation of AMR strategies? 
    Bettina Borisch – WFPHA 

Chair: Michael Moore

3:00pm – 3:30pm Afternoon Tea and networking & group photo
3:30pm – 4:00pm

“Avoiding an unwanted post-antibiotic era: establishing Antibiotic Efficacy as a Global Public Good”
Invited Speaker:Hermann Goossens

Chair: Marta Lomazzi

4.00pm – 4:45pm 

Closing remarks & Call to action
Michael Moore

WFPHA Immediate Past President & Workshop Co-Chair        

Speakers’ Biographies

AMR Workshop SpeakersAMR Workshop Speakers

1. Honorable Kwaku Agyeman Manu, Minister of Health, Ghana

Honorable Kwaku Agyeman Manu is currently the Minister of Health in Ghana. He is also the Member of Parliament for Dormaa Central. He has previous experience in the private sector as an accountant at Mim Timber Company Limited, and as the Director of Finance at Toyota Ghana Limited. Under the government of President Kufuor, he served as a Deputy Minister of State in the following Ministries: Trade & Industry, Interior, Finance, Communications, and Roads & Transport. He has served on the Board of Directors for several institutions and was the CEO of the National Health Insurance Authority in 2006. He holds a B.A. in Economics and Statistics and is an Associate Chartered Management Accountant. 


2. April Johnson, Animal Health Officer, Food and Agriculture Organization of the United Nations (FAO)

April Johnson is an Animal Health Officer in Veterinary Public Health at the FAO working on veterinary public health topics including AMR, rabies, and brucellosis. Prior to joining the FAO, Johnson spent 3 years in Azerbaijan on capacity development for the detection, development and response to particularly dangerous pathogens with the US Defense Threat Reduction Agency’s Cooperative Biological Engagement Program. She also held positions with Purdue University College of Veterinary Medicine, US, and the US Centers for Disease Control. She holds a Doctor of Veterinary Medicine from the University of Illinois, US, as well as a PhD in Virology and an MPH in Epidemiology from the University of Florida, US. 


3. Marc Sprenger, Director of the WHO Secretariat for Antimicrobial Resistance

Marc Sprenger is the Director of the WHO Secretariat for Antimicrobial Resistance, which works to coordinate an organization-wide approach to AMR, working with WHO programs to carry out technical activities required for the implementation of the global action plan on AMR. Prior to joining WHO, Sprenger was the Director of the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden and the Director-General of the National Institute for Public Health and the Environment (RIVM) in Bilthoven, the Netherlands. Sprenger is a medical doctor, a medical microbiology specialist and has a PhD in epidemiology.


4. Anette Hulth, International coordinator of the unit for Antibiotics and Infection Control, Public Health Agency of Sweden

Anette Hulth is an International Coordinator at the Unit for Antibiotics and Infection Control – a designated WHO Collaborating Centre for AMR Containment – at the Public Health Agency of Sweden. Among other activities, she is the principal investigator for a five-year One Health project on antibiotic resistance that is used in a rural part of China. She is also involved in improvement work in infection control within the framework of an EU Joint Action on AMR and infection control. Hulth has a background in computer science and previously developed a system for computer supported outbreak detection of communicable diseases, as well as an automatic syndromic surveillance system.


5. Manica Balasegaram, Director, Global Antibiotic Research & Development Partnership (GARDP)

Manica Balasegaram is the Director of GARDP. He is also currently a board member of the Medicines Patent Pool and FIND’s Scientific Advisory Committee. Balasegaram has spent many years working as a doctor and researcher in several countries in Sub-Saharan Africa and Southern Asia. He has substantial experience working in humanitarian emergencies, largely with Médecins sans Frontières (MSF), and later became the Executive Director of the MSF Access Campaign. He also spent 4 years as Head of Leishmaniasis Clinical Program for the Drugs for Neglected Diseases Initiative. Balasegaram was trained as a medical doctor at the University of Nottingham, UK, specializing in internal and emergency medicine.


6. Herman Goossens, Professor of microbiology, University Hospital, Antwerp 

Herman Goossens, MD, is a professor of Medical Microbiology and the Director of the research Laboratory of Medical Microbiology at the University of Antwerp and the Director of the Laboratory of Clinical Biology of the University Hospital Antwerp. He is a member of the WHO Advisory Group on Integrated Surveillance of AMR and coordinates many initiatives on AMR and Infectious Diseases, including Genomics to Combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE). He was the elected Chair of the Scientific Advisory Board of JPIAMR. He has published more than 650 full papers in peer-reviewed, scientific journals and has received numerous honors and awards, including the award of the American Alliance for the Prudent Use of Antibiotics (APUA).Goossens graduated with an MD from Free University of Brussels.


7. Catharina Boehme, CEO, Foundation for Innovative New Diagnostics (FIND)

Catharina Boehme is the Chief Executive Officer of FIND, an international non-profit organization that drives the development and delivery of diagnostic tests for diseases of poverty. Under Boehme’s leadership, 10 new diagnostic tools have been introduced in resource poor settings, and FIND’s scope has been expanded to include outbreak preparedness, hepatitis elimination and AMR. Prior to joining FIND in 2005, she worked for the Department of Infectious and Tropical Diseases in Munich. Boehme holds a MD from Ludwig Maximilians University in Munich and Heidelberg University, Germany, as well as diplomas in Public Health and Management.          


8. Bettina Borisch,Professor for Global Health at the University of Geneva and Director of the WFPHA

Dr. Borisch is an MD and a Pathologist, MPH and Fellow of the RCP. Her scientific research work delves into neoplastic lesions of the immune system and breast cancer, as well as community-based oncology and health communication. She teaches in the pre- and post-graduate medical curricula at the University of Geneva and has a continuing involvement in the MPH programs of the Universities of Berne, Basle and Zurich. From 1997 up until now, she has chaired the Expert Committee of the breast cancer prevention program conducted by the Swiss Cancer League. 

She is a member of the Steering Committees of the Swiss Society for Public Health, the World Federation of Public Health Associations and of the Swiss Society for Health Policy. As member of the Committee of the World Federation of Public Health Associations, she became Associate Editor of the Journal of Public Health Policy. 


9. Michael Moore, AM, President of World Federation of Public Health Associations

Michael Moore is the CEO of the Public Health Association of Australia and the President of the World Federation of Public Health Associations. He was honored for his major contribution to the protection of health in 2017 when he was made a member of the Order of Australia (AM). He is a former Minister of Health and Community Care and was an Independent member of the Australian Capital Territory Legislative Assembly. He is widely published in academia, as well as being a political and social columnist. Michael Moore holds a post-graduate degree in education, a master's degree in population health from Australian National University and is an adjunct professor with the University of Canberra where he is a PhD Scholar examining a framework for planning or evaluating health advocacy. 


10. Gary M. Cohen, President, Becton Dickinson and Co. (BD) Foundation

Gary Cohen is the Executive Vice President, Global Health of Becton, Dickinson and Co. and the President of the BD Foundation. Cohen and BD engage in extensive cross-sector collaboration to address unmet health needs globally, focusing on specific health goals, such as combating AMR. He also serves as a board director for Perrigo Company, CDC Foundation, and UNICEF USA, as well as the board chair and founder of “Together for Girls”.He previously served on the UN Commission on Life Saving Commodities for Women and Children. Cohen holds a B.A. and an M.B.A. degree from Rutgers University and previously served on the University’s Board of Trustees.


11. Viviana Muñoz Tellez, Coordinator of the Development, Innovation, and Intellectual Property Program, South Center

Viviana Muñoz Tellez is the Coordinator of the Development, Innovation and IP Program of the South Center - an intergovernmental organization of developing countries. Muñoz coordinates the research, policy advice and capacity building work on public health, innovation and IP. She participates in the Interagency Coordination Group on AMR (IACG). Prior to joining the SC, Muñoz worked at Queen Mary Intellectual Property Research Institute at the University of London. She holds a PhD in Management of Technology from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, with a focus in economics of medical innovation, and an MS in Development Management from the London School of Economics, UK.

12. Peter Beyer,Senior Advisor with the World Health Organization (WHO)

Peter Beyer is a Senior Advisor with the WHO in Geneva, where he is responsible for issues related to public health, trade and intellectual property and leads a team on AMR. He is responsible for the development of a Global Development and Stewardship Framework for AMR. He was instrumental in the creation of GARDP, as well as the trilateral collaboration among WIPO, WTO, and WHO.Previously, Beyer was a Legal Advisor to the Swiss Federal Institute of Intellectual Property, in Berne, negotiated bilateral free trade agreements for the European Federal Trade Association (EFTA), and has worked on environmental law and policy. He is a trained lawyer, having received degrees from the Universities of Cologne and Freiburg.


13. Howard Catton, Director of Nursing and Health Policy, International Council of Nurses (ICN)

Howard Catton is the Director of Nursing and Health Policy at the ICN and leads the development of ICN policy across workforce, education, regulation, nursing practice and health policy. He held previous positions at the Royal College of Nursing UK, the New Zealand Nursing Organization, and as the Head of Policy & International Affairs at the RCN. He has also worked as a Personnel and Organizational Change Manager in the NHS in the UK. Catton was named in the Health Service Journal top 100 Clinical Leaders list for 2015. Howard Catton became a Registered Nurse in the UK in 1988, and later went on to study social policy in Cardiff (BSc Econ) and Industrial Relations at Warwick (MA). 


14.Sonja Löfmark, Analyst for Antibiotic and Infection Control, Public Health Agency of Sweden

Sonja Löfmark works with the international collaborations at the unit for Antibiotic and Infection Control at the Public Health Agency of Sweden. Primarily, she coordinates collaboration with the WHO on global AMR surveillance and is involved in the implementation of the WHO global surveillance system. Other areas of responsibility include national surveillance of AMR. Löfmark also has experience in project management, and in cross-sectorial projects focusing on a one health approach on AMR. She holds a PhD in clinical bacteriology and AMR from Karolinska Institute and did a post doc at Uppsala University and Stockholm University.


15. Mohammed Yassin, Senior Disease Advisor for Tuberculosis (TB), The Global Fund

Mohammed Yassin is a Senior TB Advisor at the Global Fund in Geneva. He is the focal person for drug-resistant TB and has been working to collaborate with partners on initiatives relating to both TB and AMR. He has worked as a Physician and Regional TB/HIV program coordinator in his country of Ethiopia, as well as an Epidemiologist Research Fellow at the Liverpool School of Tropical Medicine, UK. He has published over 50 papers on TB/MDR-TB. He is a medical doctor and an Infectious Disease Epidemiologist with over 20-years of experience in TB/MDR-TB. He has extensive experience in program design, implementation, research, strategic investment of resources, and prioritization of interventions. 


16. Denise Delaney, Director, SustainAbility

Denise Delaney is the Director of SustainAbility, where she leads strategy and stakeholder engagement projects, as well as the organization’s work on health with the pharmaceutical industry. She led the development of the metrics framework and the first progress report for the AMR Industry Alliance. She has also worked with AstraZeneca, GlaxoSmithKline, J&J, IFPMA, Novartis and Novo Nordisk. Her work with the industry spans materiality assessments, Access to Medicine Index (ATMI) performance assessments and stakeholder engagement strategy. She is an expert in stakeholder engagement strategies. She holds a B.A. in Social Anthropology from Harvard University and an MSc in Forced Migration from Oxford University. 


17. Roger Harrison, Senior Lecturer in Public Health, University of Manchester

Roger Harrison (PGCert, PGDip, BA, MPhil, MPH, PhD) is a Senior lecturer in Public Health at the University of Manchester. His primary responsibility is to lead postgraduate education opportunities for the global public health workforce. His research interests include methods for assessing population risk of chronic disease and impact of lifestyle interventions. Three years ago, with the support of the University of Manchester, Harrison implemented an upstream, social-asset based approach to public engagement, education and support for antibiotic drug resistance called, “Action on Antibiotic Drug Resistance: One student, one campus, one world”. The course is currently delivered to over 10,000 globally dispersed students.

18. Nina Renshaw, Secretary-General European Public Health Alliance (EPHA)

Nina Renshaw is the Secretary-General of the European Public Health Alliance (EPHA). Renshaw co-leads EPHA's AMR Campaign and represents EPHA on the SDG Watch Europe and the Social Platform. Prior to joining EPHA, she served as the Deputy Director of Transport & Environment, a Brussels-based environmental group. She has a degree in International Business from the UK, and an M.A. in European Policy and Politics from Humboldt University in Berlin and Bath University (UK), where she specialized in civil society and policy-making. 

19. Thomas Tängdén, Medical Director, ReAct Europe

Thomas Tängdén (MD, PhD) is currently the Medical Director at ReAct, Action on Antibiotic Resistance, an independent network dedicated to the problem of antibiotic resistance. He is an infectious disease specialist at Uppsala University Hospital and an associate professor of infectious diseases at Uppsala University, Sweden. As a clinician and researcher, his main focus is to optimize treatment for infections caused by multidrug-resistant, Gram-negative bacteria and to promote appropriate antibiotic use. Previously, he chaired the programme committee of the Uppsala Health Summit 2015 – “A world without antibiotics” – and launched the Massive Open Online Course “Antibiotic resistance – the silent tsunami” to educate the public.

20. Caline Mattar, Instructor in Medicine, World Medical Association

Caline Mattar is an Infectious Diseases Faculty Member at the Washington University in St. Louis. She also serves as the Chair of the Junior Doctors Network and the AMR Lead for the World Medical Association. She has followed the development and implementation of the Global Action Plan on AMR and has contributed to several expert consultations. Mattar completed her medical school training at the American University of Beirut in Lebanon. She moved to the U.S. to complete a Residency in Internal Medicine and a Fellowship in Infectious Diseases, with a focus on Bloodstream Infections, Antimicrobial Resistance and Infection Prevention in Resource Limited Settings.


21.Christoph Spennemann, Legal Officer, UNCTAD

Christoph Spennemann oversees the Intellectual Property (IP) Unit at the UN Conference on Trade and Development (UNCTAD). He leads a program on investment and IP for developing countries. He deals with issues regarding IP rights and their development implications. He is also organizing a session on “Fostering investment in the development of new antibacterial treatments” at UNCTAD’s World Investment Forum in October 2018. He holds a Master degree in International Economic Law and European Law from the Universities of Lausanne and Geneva (Switzerland) and studied law at the universities of Passau and Freiburg (Germany) and Grenoble (France). After his bar examination, Spennemann practiced law in Berlin. 


22. Renuka Gadde,Vice President Global Health, Becton Dickinson and Co. (BD)

Renuka Gadde is the Vice President, Global Health at BD. She provides leadership for BD’s Global Health initiatives in emerging and developing countries. This requires extensive external engagement with ministries of health, international agencies, including WHO, UNICEF, CDC, and UNAIDS, and NGO’s, such as The Global Fund, FIND, and the Bill and Melinda Gates Foundation. These partnerships drive product access, policy and advocacy and source external funding for the advancement of Global Health innovation. Her previous positions at BD include Regional Immunization Director for the Asia Pacific Region, and the Director of Strategic Planning for the Medical Segment. She holds a Master’s degree in Business Administration. 


23. Stefano Aliberti, Professor in Respiratory Medicine, University of Milan

Stefano Aliberti is a Professor in Respiratory Medicine at the University of Milan and a consultant at the Policlinico University Hospital, Milan, Italy. Most of his research over the past ten years has been focused on both acute and chronic respiratory infections, especially community-acquired pneumonia and multi-drug resistance (MDR). He developed the first European clinical score to predict community-acquired pneumonia due to MDR bacteria. He received his medical degree from the University of Milan and completed his clinical research training at the University of Louisville, KY, USA, working as the director of the Community-Acquired Pneumonia Organization Database.

24. Amanda Howe, President of the World Organization of Family Doctors (WONCA) and Professor of Primary Care at the University of East Anglia (UEA)

Amanda Howe is a practicing family doctor, an academic professor, and a national and international leader in family medicine. Since 2001, she has been Professor of Primary Care at the University of East Anglia, where she has held multiple roles in undergraduate, postgraduate, and faculty education, including being Course Director for the UEA medical program during its early years of development and accreditation. She served from 2009 – 2015 as an Officer of the Royal College of General Practitioners and is President of the World Organization of Family Doctors from 2016-2018.

25. Philip Howard, Consultant Pharmacist in AMR, International Pharmaceutical Federation (FIP)

Philip Howard is a Consultant Pharmacist in Antimicrobials at the Leeds Teaching Hospitals NHS Trust, an Honorary Senior Lecturer at Leeds University, and is seconded part time to NHS England as an AMR and Healthcare Associated Infection project lead. Howard has been active in the field of Antimicrobial Stewardship (AMS) for many years, including involvement in the national Antimicrobial Prescribing and Stewardship Competences. Howard is the Vice President (President-Elect) of the British Society for Antimicrobial Chemotherapy (BSAC), a member of the UK Clinical Pharmacy Association (UKCPA) Pharmacy Infection Network and has represented FIP on the WHO AMR Strategy.

26. Rosanna Peeling,Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine and Director of the International Diagnostic Centre (IDC)

Rosanna Peeling is currently Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine and Director of the International Diagnostic Centre (IDC). Trained as a medical microbiologist, she was Research Coordinator and Head of Diagnostics Research at the WHO Special Program on Research and Training in Tropical Diseases (WHO/TDR) in Geneva before assuming her current position. Her work focuses on research to define unmet diagnostic needs, facilitate test development, evaluation and implementation in the developing world. She established the IDC to advocate the value of diagnostics, foster innovation, and accelerate access to quality-assured diagnostics to improve global health. In 2014, Professor Peeling was awarded the Royal Society of Tropical Medicine’s George MacDonald Medal, becoming the first woman to receive this honor.

27. Nicholas Kitchin, Senior Director, Pfizer Vaccine Clinical Research and Development Group

Nicholas Kitchin is Senior Director of Pfizer’s Vaccine Clinical Research and Development group. He provides global medical leadership for clinical trials of Pfizer’s investigational Clostridium difficilevaccine. After initial training in anaesthesiology, Kitchin joined the pharmaceutical industry, and has specialized in the field of vaccines since 1994. He earned his medical degree from the University of London in 1991 and is a Fellow of the Faculty of Pharmaceutical Medicine at the Royal Colleges of Physicians of the United Kingdom. Having held a plethora of positions regarding vaccines, he is a passionate advocate for the public health benefits of vaccination.

Sponsors’ Profiles

American Public Health Association

The American Public Health Association (APHA) champions the health of all people and communities by voicing public health issues and policies backed by science. APHA is the only organization in the US that influences federal policy, has a nearly 150-year perspective and unites members from all fields of public health.


Becton, Dickson & Co. (BD) is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.


FIND is an international non-profit organization based in Geneva, Switzerland. The organization is dedicated to activities that result in: 1) new diagnostic tools for poverty-related diseases in low- and middle-income countries; 2) expanded access to these tools; and 3) strengthened diagnostic testing capacity in low- and middle-income

Global Antibiotic Research and Development Partnership

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit research and development (R&D) organization that addresses global public health needs by developing and delivering new or improved antibiotic treatments, while endeavouring to ensure their sustainable access. GARDP is an important element of WHO’s Global Action Plan on Antimicrobial Resistance.

Institute of Global Health

The Institute of Global Healthwas founded in January 2014 as a transformation of the former Institute of Social and Preventive Medicine. This transformation was decided by the University of Geneva as a continuation of efforts to develop academic global health given the unique location of Geneva in the field.

Merck Global Health Institute

The Merck Global Health Institute is committed to improving the health of underserved populations, that lack access to health solutions including prevention, diagnostics and therapy. The Institute is working to address key unmet medical needs related to infectious diseases such as schistosomiasis and malaria (including co-infections) as well as bacterial infections and related antimicrobial

Public Health Association of Australia

The Public Health Association of Australia (PHAA) is recognised as the principal NGO for public health in Australia that promotes the health and well-being of Australians. The PHAA ensures that the public’s health is improved through efforts of the Board, the National Office, the State and Territory Branches, the SIGs and

Public Library of Science

The Public Library of Science (PLOS) is a nonprofit Open Access publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by transforming research communication. PLOS journals contain rigorously peer-reviewed Open Access research. The PLOS Antimicrobial Resistance Channel is a dedicated research discovery site for the AMR community.

World Federation of Public Health Associations

The World Federation of Public Health Associations (WFPHA) is an international NGO composed of over 115 associations member, representing around 5 million public health professionals worldwide. It is the only worldwide professional society representing and serving the broad field of public health. WFPHA’s mission is to promote and protect global public health.

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInShere with friendsDisplay print-friendly version